Dna XSONM
13F holders, Q4 2025 (December 31)8holders
$3.15avg. 13F price*
At the end of Q4 2025, 8 institutions reported holding Dna X Inc. (SONM) in their 13F filings. The largest holders were Potomac Capital Management, Inc. ($151K), BlackRock, Inc. ($44K) and Cannell Capital LLC ($43K).
- Company
- Dna X Inc.
- Filed as
- SONIM TECHNOLOGIES INC (Q4 2025)
- CUSIP
- 83548F408
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $43K |
| Exits | 0 | $0 |
Ownership 8 holders
| Potomac Capital Management, Inc. | 0.13% | — | 48,000 | $151K |
| BlackRock, Inc. | 0.00% | Add +0.1% | 14,006 | $44K |
| Cannell Capital LLC | 0.03% | New | 13,626 | $43K |
| UBS Group AG | 0.00% | Add +4076.3% | 8,682 | $27K |
| SBI Securities Co., Ltd. | 0.00% | Reduce -0.1% | 214 | $674 |
| Bank of America Corp. | 0.00% | Reduce -63.8% | 4 | $13 |
| Danske Bank A/S | 0.00% | Add +7111.5% | 4 | $13 |
| BNP Paribas Financial Markets | 0.00% | Reduce -14.2% | 1 | $3 |
"% of holder's portfolio" is SONM's weight in each manager's 13F, not the share of Dna X Inc. the manager owns.